Position in IBRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,949,598
+$2,480,395 QoQ
Shares Held
451,125
+135.5% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 403 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 69%
None 31%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. IBRX ranks #46 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in IBRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,949,598 | 451,125 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,469,203 | 191,552 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $97,863 | 49,426 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $104,247 | 42,377 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $166,206 | 62,957 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $118,747 | 39,451 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $112,650 | 44,004 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $173,262 | 46,576 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $1,140,443 | 180,450 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $235,173 | 43,794 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $266,371 | 53,062 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $77,721 | 45,989 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $121,310 | 43,637 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $57,177 | 31,416 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $159,279 | 31,416 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $156,137 | 31,416 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $116,867 | 31,416 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $147,284 | 26,254 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $159,624 | 26,254 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $257,827 | 26,471 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $378,005 | 26,471 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $328,063 | 13,819 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 NK | — | 14,445 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 NK | — | 10,727 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||